WELLS FARGO & COMPANY/MN
Position in PTGX — Protagonist Therapeutics, Inc
CIK 72971
SAN FRANCISCO, CA
Position in PTGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,818,893
+$5,649,305 QoQ
Shares Held
71,944
+139.2% QoQ
Ownership
0.111%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#78
of 341 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,774,320 across 417 Biotechnology names. PTGX ranks #32 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in PTGX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,818,893 | 71,944 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $3,169,588 | 30,072 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $6,257,473 | 71,645 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $3,174,955 | 47,794 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,304,040 | 41,687 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,925,162 | 39,809 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,497,524 | 38,796 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,321,785 | 29,373 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,046,082 | 30,190 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $861,909 | 29,793 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $370,479 | 16,157 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,277,086 | 76,564 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,962,426 | 71,051 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $781,172 | 33,964 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $403 | 37 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $19,758 | 2,344 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $44,491 | 5,625 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $616,128 | 26,019 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,380,242 | 40,358 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,040,676 | 58,729 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,347,206 | 30,018 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $995,465 | 38,435 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $1,482,384 | 73,531 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $513,069 | 26,244 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $264,351 | 14,969 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $342,726 | 48,545 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||